The Microbe,
Год журнала:
2024,
Номер
4, С. 100143 - 100143
Опубликована: Авг. 15, 2024
The
emergence
of
the
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
as
a
global
threat
has
driven
urgent
need
for
identification
bioactive
molecules
capable
controlling
or
completely
eradicating
this
virus.
Our
group
been
investigating
isatin
hybrids
that
block
binding
human
angiotensin-converting
enzyme
(ACE2)
and
viral
spike
protein.
This
work
describes
synthesis
biological
evaluation
two
derivatives
(indol-2,3-dione)
based
on
computational
approach.
Isatin,
secondary
metabolite
tryptophan,
used
core
structure
is
versatile
favorable
precursor
privileged
scaffold
against
complex.
new
compound
scaffolds
AVS-01
AVS-02
were
designed
by
modifications
at
C-3
N-1
positions,
respectively,
according
to
various
reagents
available
in
our
lab.
Molecular
docking
compounds
was
explore
their
interactions
with
target
protein
shown
article
showed
quite
distinct
glide
scores
(GScore
=
−3.657
−4.534
AVS-02,
respectively).
Several
analogs
synthesized
tested
quest
find
plausible
further
synthesis.
While
inhibition
spike/ACE2
an
IC50
value
8.8
µM,
reference
hopeaphenol
inhibited
interaction
0.3
µM.
Compound
rather
no
SARS-CoV-2
spike/host
ACE2
>
32
An
estimation
free
energy
(ΔGbind),
solvation
(ΔGsolv)
MM-GBSA
calculations
carried
out
re-evaluate
affinity
gain
insights
into
observed
activity
non-activity.
calculation
ΔGbind
−35.91
kcal/mol
and-25.32
ΔGsolv
25.56
16.92
respectively.
leads
conclusion
position
indole-2,3-dione
moiety
favors
blockage
compared
position.
Analysis
GScores,
per-residue
energies,
energies
van
der
Waals
should
favor
towards
Journal of Natural Products,
Год журнала:
2024,
Номер
87(4), С. 849 - 854
Опубликована: Фев. 28, 2024
Microthecaline
A
(1),
the
known
antiplasmodial
quinoline
serrulatane
alkaloid
from
roots
of
Eremophila
microtheca
F.
Muell.
ex
Benth.
(Scrophulariaceae),
was
targeted
for
isolation
and
subsequent
use
in
generation
a
semisynthetic
ether
library.
large-scale
extraction
yielded
previously
undescribed
microthecaline
B
(2),
along
with
crystalline
1
that
enabled
first
X-ray
crystallographic
analysis
to
be
undertaken
on
this
rare
structure
class.
The
diffraction
supported
absolute
configuration
assignment
A,
which
originally
assigned
by
ECD
data
analysis.
(1)
converted
into
10
new
derivatives
(3–12)
using
diverse
series
commercially
available
alkyl
halides.
Chemical
structures
analogues
were
spectroscopic
spectrometric
analyses.
Antiplasmodial
evaluations
1–12
showed
derivative
5
elicited
most
potent
activity
an
IC50
value
7.2
μM
against
Plasmodium
falciparum
3D7
(drug-sensitive)
strain.
Journal of Natural Products,
Год журнала:
2024,
Номер
87(6), С. 1513 - 1520
Опубликована: Май 23, 2024
Current
small-molecule-based
SARS-CoV-2
treatments
have
limited
global
accessibility
and
pose
the
risk
of
inducing
viral
resistance.
Therefore,
a
marine
algae
cyanobacteria
extract
library
was
screened
for
natural
products
that
could
inhibit
two
well-defined
validated
COVID-19
drug
targets,
disruption
spike
protein/ACE-2
interaction
main
protease
(M
RSC Advances,
Год журнала:
2024,
Номер
14(29), С. 21203 - 21212
Опубликована: Янв. 1, 2024
The
coronavirus
disease
2019
(COVID-19)
has
spread
worldwide
with
severe
health,
social,
and
economic
repercussions.
Although
vaccines
have
significantly
reduced
the
severity
of
symptoms
deaths,
alternative
medications
derived
from
natural
products
(NPs)
are
vital
to
further
decrease
fatalities,
especially
in
regions
low
vaccine
uptake.
When
paired
latest
computational
developments,
NPs,
which
been
used
cure
illnesses
infections
for
thousands
years,
constitute
a
renewed
resource
drug
discovery.
In
present
report,
combination
vitro
methods
reveals
repositioning
NPs
identifies
salvinorin
A
deacetylgedunin
(DCG)
as
having
potential
anti-SARS-CoV-2
activities.
Salvinorin
was
found
both
silico
inhibit
SARS-CoV-2
spike/host
ACE2
protein
interactions,
consistent
blocking
viral
cell
entry,
well
live
virus
replication.
Plant
extracts
Azadirachta
indica
Cedrela
odorata,
contain
high
levels
DCG,
inhibited
replication
by
targeting
main
protease
(Mpro)
and/or
entry
interaction
between
spike
RBD-ACE2
at
concentrations
lower
than
A.
Our
findings
suggest
that
represent
promising
chemical
starting
points
where
optimization
may
result
effective
product-derived
potent
inhibitors
supplement
efforts.
The Microbe,
Год журнала:
2024,
Номер
4, С. 100143 - 100143
Опубликована: Авг. 15, 2024
The
emergence
of
the
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
as
a
global
threat
has
driven
urgent
need
for
identification
bioactive
molecules
capable
controlling
or
completely
eradicating
this
virus.
Our
group
been
investigating
isatin
hybrids
that
block
binding
human
angiotensin-converting
enzyme
(ACE2)
and
viral
spike
protein.
This
work
describes
synthesis
biological
evaluation
two
derivatives
(indol-2,3-dione)
based
on
computational
approach.
Isatin,
secondary
metabolite
tryptophan,
used
core
structure
is
versatile
favorable
precursor
privileged
scaffold
against
complex.
new
compound
scaffolds
AVS-01
AVS-02
were
designed
by
modifications
at
C-3
N-1
positions,
respectively,
according
to
various
reagents
available
in
our
lab.
Molecular
docking
compounds
was
explore
their
interactions
with
target
protein
shown
article
showed
quite
distinct
glide
scores
(GScore
=
−3.657
−4.534
AVS-02,
respectively).
Several
analogs
synthesized
tested
quest
find
plausible
further
synthesis.
While
inhibition
spike/ACE2
an
IC50
value
8.8
µM,
reference
hopeaphenol
inhibited
interaction
0.3
µM.
Compound
rather
no
SARS-CoV-2
spike/host
ACE2
>
32
An
estimation
free
energy
(ΔGbind),
solvation
(ΔGsolv)
MM-GBSA
calculations
carried
out
re-evaluate
affinity
gain
insights
into
observed
activity
non-activity.
calculation
ΔGbind
−35.91
kcal/mol
and-25.32
ΔGsolv
25.56
16.92
respectively.
leads
conclusion
position
indole-2,3-dione
moiety
favors
blockage
compared
position.
Analysis
GScores,
per-residue
energies,
energies
van
der
Waals
should
favor
towards